- Research article
- Open Access
- Open Peer Review
This article has Open Peer Review reports available.
Maternal and neonatal colonisation of group B streptococcus at Muhimbili National Hospital in Dar es Salaam, Tanzania: prevalence, risk factors and antimicrobial resistance
© Joachim et al; licensee BioMed Central Ltd. 2009
Received: 18 June 2009
Accepted: 01 December 2009
Published: 01 December 2009
Group B streptococcus (GBS), which asymptomatically colonises the vaginal and rectal areas of women, is the leading cause of septicemia, meningitis and pneumonia in neonates. In Tanzania no studies have been done on GBS colonisation of pregnant women and neonates. This study was conducted in Dar es Salaam, Tanzania to determine the prevalence of GBS colonisation among pregnant women, the neonatal colonisation rate and the antimicrobial susceptibility, thus providing essential information to formulate a policy for treatment and prevention regarding perinatal GBS diseases.
This cross sectional study involved 300 pregnant women attending antenatal clinic and their newborns delivered at Muhimbili National Hospital (MNH) between October 2008 and March 2009. High vaginal, rectal, nasal, ear and umbilical swabs were cultured on Todd Hewitt Broth and in 5% sheep blood agar followed by identification of isolates using conventional methods and testing for their susceptibility to antimicrobial agents using the Kirby-Bauer method.
GBS colonisation was confirmed in 23% of pregnant women and 8.9% of neonates. A higher proportion of GBS were isolated from the vagina (12.3%) as compared to the rectum (5%). Prolonged duration of labour (>12 hrs) was significantly shown to influence GBS colonisation in neonates P < 0.05. Other risk factors such as prolonged rupture of membrane, intrapartum fever, low birth weight and HIV infection did not correlate with GBS colonisation. All isolates were sensitive to vancomycin and ampicillin. Resistance to clindamycin, erythromycin and penicillin G was found to 17.6%, 13% and 9.4%, respectively.
Our findings seem to suggest that a quarter of pregnant women attending ANC clinic at MNH and approximately 10% of their newborns are colonised with GBS. All isolates were found to be sensitive to vancomycin and ampicillin which seem to be the most effective antibiotics for the time being. However there is a need for continuous antibiotics surveillance of GBS to monitor trend of resistance. The high isolation frequency of GBS among pregnant women suggests routine antenatal screening at 35 to 37 weeks of gestation in order to provide antibiotic prophylaxis to GBS carrier.
Group B Streptococcus (GBS) is now recognized to be an important cause of maternal and neonatal morbidity and mortality in many parts of the world [1, 2]. GBS infections tend to occur more commonly among adults than in neonates, but the overall mortality is higher in neonates . Risk of disease is greater in pregnant women than in men and non-pregnant women. At birth, infants who are born to colonized mothers may also become colonised on their mucosal surfaces such as oral, nasopharynx, vaginal and anal mucosa and skin . Approximately 60% of infants born to colonised mother become colonised with their mother's organisms . The likelihood of neonatal colonisation at birth is higher if the mother is heavily colonised .
GBS infection is the leading cause of perinatal bacterial infection , being commonly responsible for septicemia, meningitis and pneumonia in neonates. However, the burden of perinatal GBS disease varies between countries. Intrapartum antimicrobial prophylaxis to GBS carriers has been reported to be effective in reducing GBS disease. Prevention guidelines for perinatal GBS disease were issued by Centers for Disease Control and Prevention (CDC) in 1996, and revised in 2002 [6, 7]. Since its introduction, the incidence of early-onset neonatal infections has decreased by 62% .
In Tanzania, as is the case in several other sub-Saharan countries in Africa, the rate of GBS colonisation among pregnant women and neonates has not been studied and therefore to date no strategies have been formulated to prevent neonatal GBS infection in the country. Thus the aims of this study was to determine the prevalence and risk factors of maternal and neonatal colonisation with GBS at Muhumbili National Hospital (MNH), Dar es Salaam Tanzania in order to generate local data that will inform the development of rational interventions for GBS infection and disease.
Study design and setting
This was a hospital based cross-sectional study conducted at Muhimbili National Hospital (MNH), Dar es Salaam, Tanzania between October 2008 and March 2009. MNH is a tertiary facility which handles referrals from peripheral and upcountry hospitals.
The study included 300 third trimester pregnant women (from 37 weeks of gestation) attending the antenatal clinics at MNH for routine antenatal visits and their neonates (180) delivered at the MNH labor ward. Sample size was calculated from the following formula n = z2p (100-p)/e2 where p, in the absence of local data, was taken as the median prevalence of GBS carriage among pregnant women in African countries (16%) [8, 9]. All consenting mothers with gestation age ≥ 37 weeks were included. Participants with history of using antibiotic(s) within two weeks prior to recruitment were excluded from the study.
Data was collected after obtaining written informed consent using a standard structured questionnaire designed to obtain social demographic data and other relevant information such as maternal age, gestational age, previous obstetric history, history of current pregnancy, parity, marital status, mode of delivery, administration of antibiotics during labor and neonate's birth weight. Pregnant women were interviewed at 37 weeks of gestation, during labour and after delivery.
Specimen collection and transport
High vaginal and rectal swabs were collected at 37 weeks of gestation using sterile swab stick. In addition, umbilical swabs, ear canal and nasal swabs were collected from neonates within one hour after delivery. The swabs were inoculated directly into Todd Hewitt Broth (Oxoid Ltd) and transported to the central pathology laboratory of the MNH for processing within 2 hours of collection. About three millilitres of venous blood were drawn aseptically into sterile vacutainer tubes (BD NJ USA) without anticoagulant for detection of HIV antibodies and in EDTA (BD NJ USA) vacutainer tubes for quantification of CD4+T lymphocytes counts.
The swabs were inoculated in Todd-Hewitt broth (Oxoid Ltd) containing nalidixic acid (15 mg/L) and gentamicin (8 mg/L) and incubated at 37°C in 5% Co2 for 24 h. Subcultures were performed in 5% sheep blood agar for isolation of GBS. Broth cultures showing no visible turbidity after overnight incubation were further re-incubated and then sub cultured after 48 hours on sheep blood agar. Presumptive identification of GBS was made by traditional physiological and biochemical methods. These included Gram stain, catalase reaction, hemolytic activity on sheep blood agar plates, hippurate and CAMP tests. Confirmative identification of Group B Streptococcus was done using Streptex- agglutination test (Remel Europe Ltd). Finally, antimicrobial susceptibility of all GBS isolates was determined by Kirby-Bauer disk diffusion method according to Clinical Laboratory Standard Institute (formerly NCCLS). The antimicrobials included; penicillin G (10 U), ampicillin (10 μg), clindamycin (2 μg.), erythromycin (15 μg), vancomycin (30 μg), ciprofloxacin (5 μg), ceftriaxone (30 μg) and co-trimoxazole 25 μg. S. agalactiae ATCC 27956 was used as a control organism.
HIV testing was done using Tanzania's National HIV rapid test algorithm . SD-Bioline HIV 1/2 (SD Standard Diagnostic, Inc Korea) was used for initial screening and reactive samples were confirmed by Determine™ (Abbott Laboratory, Tokyo Japan). A sample was considered seronegative if it was non reactive at screening and seropositive when reactive on both assays. There were no discordant samples.
CD4+ T lymphocytes enumeration
This was determined by using Becton Dickson FACS Calibur flow cytometry.
Data was analysed using SPSS for windows version 13.0 . Comparison of proportions of maternal and neonatal colonisation of GBS and statistical significance of GBS in HIV infected and non HIV infected pregnant women colonised with GBS were tested by using the Pearson's Chi-squared test (χ2). Where the numbers in a cell was less than five, a Fisher's exact test was used. P-values ≤ 0.05 were considered statistically significant.
Ethical and research clearance was obtained from Muhimbili University of Health and Allied Sciences (MUHAS) Senate Research and Publication Committee. A written informed consent was obtained from each participant prior to enrolment. HIV- pre and post test counselling were provided to the participants according to the Tanzania national guidelines for HIV testing and counselling . Any other requested additional information was provided to participants by study personnel. HIV positive women were offered prevention of mother to child transmission (PMTCT) services and also referred to HIV care and treatment clinic within MNH for further management, according to the National guidelines for Care and Treatment, Ministry of Health, Tanzania. GBS results of neonates were relayed to attending doctors for their management. All participants' results were kept confidentially.
Three hundred pregnant women (from 37 weeks of gestation) and 180 neonates were enrolled in the study between October and March 2009. There was loss of follow up of 120 neonates, due to the fact that not all pregnant women delivered at MNH. GBS were isolated from 69 (23%) pregnant women and from16 (8.9%) neonates. Vaginal carriage rate was higher 37 (12.3%) than rectal colonisation rate 15(5%). The proportion of GBS isolated from both sites was 17(5.7%).
Association between social demographic factors and GBS colonisation among pregnant women
Number of sexual
Association between obstetric factors, HIV infection and GBS colonisation among pregnant women n = 300
Previous obstetric history
Normal healthy baby
Women with previous history of stillbirth had higher rate (28.6%) of GBS colonisation followed by those with normal previous obstetric history (23.2%) and with history of spontaneous abortion (11.1%) (P > 0.05). No GBS colonisation was observed in women with previous history of premature labour. Sixty four (23.4%) of the women with GBS colonisation had no history of dysuria. In this study urine culture was not done in patients with dysuria.
HIV infection was detected in 24/300 (8%) of the study population, among whom 2/24 (8.3%) had GBS colonisation (P > 0.05) and one had CD4 T-cell count less than 200 cells/μL and the other had CD4 T-cell count above 200 cells/μl.
Association between obstetric factors and GBS colonisation rate in neonates (n = 180)
Mode of delivery Vaginal delivery
Time of membrane rupture
≤ 18 hrs
Antibiotic use before/during labour
Duration of labour
≤ 12 hrs
Weight of baby
≥ 2.5 kg
Antimicrobial Sensitivity pattern of GBS isolated from pregnant women and neonates
GBS isolation (% of sensitivity)
This study at the MNH in Dar es Salaam, Tanzania shows the overall prevalence of GBS among pregnant women and neonates to be 23% and 8.9%, respectively. These findings are consistent with reports from other developing countries [8, 13], but lower than those reported in Zimbabwe 31.6% and Trinidad 32.9% [9, 14], indicating significant country variations . The variations between countries could possibly be due, at least in part, to differences in sampling sites and techniques. For instance, in this study due to investigating sexually transmitted infections, we used high vaginal swabs which is in keeping with some previous studies [9, 16], while others investigators have used lower third of vaginal site [5, 6]. Other variations in isolation frequency could be due differences in culture methods, and type of culture media used as well as populations investigated .
In this study vaginal carriage rate (12.3%) was higher than rectal colonisation rate (5%), which is comparable to a study done in Zimbabwe by Moyo et al  in which vaginal and rectal colonisation rates were 12.6% and 6.3%, respectively. The fact that GBS was at times isolated from one and not the other site clearly indicate that it is important to sample both vagina and rectum when screening for GBS carriage in pregnant women.
Notably, there was loss of 120 neonates to follow up due to the fact that mothers delivered in other facilities. One twenty neonates made 40% of neonates and this could have affected the reported neonatal colonisation rate.
Samples cultured from mothers and neonates showed that 37% of the pairs had positive GBS culture results, which is in keeping with other studies reporting transmission rates ranging from 29% to 85% [17, 18].
Of all the factors investigated, maternal colonisation was significantly higher in women of gestation age between 41 and 42 weeks compared to women of gestation age between 39 and 40 weeks, indicating an increase GBS carriage with gestation age. The other maternal factors including social demographic factors were not significantly associated with GBS colonisation.
In the present study GBS was isolated more frequently from women of age group 30-34 (32.1%) compared with women aged <20 years (15.4%), which is in contrast with reports from another study showing high isolation frequencies in women younger than 20 years . These differences are difficult to explain but possibly underscore the fact that GBS colonisation might be influenced by multiple factors which may vary from one geographical location to another.
This study revealed that women with no formal education (34.8%) were more likely to be colonised with GBS, a finding that is consistent with observations by Regan et al . The association could be partly explained by the difference in personal hygiene, which is more likely to be better among educated than the less educated women.
GBS colonisation in the studied population was not associated with either HIV infection or CD4+ T cell count, probably due to the small sample of HIV infected pregnant women among the studied population and the fact that only one woman had CD4 counts < 200 cells/μl.
Of all possible factors for GBS colonisation in neonates that were investigated only prolonged duration of labour showed significant association, P < 0.001, probably due to prolonged exposure of the neonate in the birth canal. The strong association between prolonged labour and GBS colonisation calls for routine antibiotic prophylaxis in such women in order to decrease the chances of subsequent neonatal infection.
Other risk factors such as prolonged rupture of membrane, intrapartum fever, mode of delivery and low birth weight did not influence GBS colonisation in neonates. The lack of association with these factors can possibly be explained by the fact that the numbers of participants in this study with such risk factors were small (2%). We did not investigate the timing of caesarean section in relation to prelabor and post labour rupture of membrane versus spontaneous vaginal delivery, which could be viewed as one of the limitations of the study. However, the small number of women who delivered by caesarean section may not show any potential association.
Notably all GBS isolated were sensitive to ampicillin and vancomycin, implying that these two antibiotics could be used for empiric prophylaxis. Most isolates (90% to 98%) were sensitive to ciprofloxacin and penicillin G and (80% to 90%) sensitive to clindamycin, erythromycin and ceftriaxone indicating the current value of these different antibiotics in the treatment and prophylaxis of GBS infection in Dar es Salaam.
The high prevalence of GBS colonisation among pregnant women and neonates calls for screening of this bacterium in women attending antenatal care so that intrapartum antimicrobial prophylaxis can be offered to all women identified as carriers.
The authors would like to acknowledge the technical support provided by the members of the Departments of Microbiology and Immunology and Gynecology and Obstetrics of the Muhimbili University of Health and Allied Sciences in Dar es Salaam. We thank Mrs. Elizabeth Manda and Mary Nyange who performed the laboratory work. We are grateful to the administration Muhimbili National Hospital for supporting the study. We acknowledge statistical support provided by Dr. Candida Moshiro of the Department of Biostatistics at the Muhimbili University College of Health Sciences. We appreciate the participation of our clients without whom this study would have not been possible.
- Schuchat A: Epidemiology of Group B Streptococcal Disease in the United States: Shifting Paradigms. Clin Microbiol Rev. 1998, 11: 497-513.PubMedPubMed CentralGoogle Scholar
- Timothy SC, Maritza C, Robert HG, Aldo V, Patricia C: Group B streptococcal colonisation in a developing country: Its association with sexual transmitted disease and socioeconomic factors. Am J Trop Med Hyg. 1998, 59: 633-636.Google Scholar
- Patrick RM, Ken SR, George SK, Michael AP: Medical Microbiology. 2002, Philadelphia: Churchill Livingstone, 23: 217-235. fourthGoogle Scholar
- Schuchat A, Wenger JD: Epidemiology of group B streptococcal disease. Epidemiol Rev. 1994, 16: 374-402.PubMedGoogle Scholar
- Committee on Infectious Diseases and Committee on Foetus and Newborn: Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. Pediatr. 1992, 90: 775-8.Google Scholar
- Center for Disease Control and Prevention: Prevention of perinatal group B streptococcal disease. MMWR. 2002, 51 (RR-11): 1-22.Google Scholar
- Edwards MS, Baker CJ: Streptococcus agalactiae. Principles and Practice of Infectious Diseases. Edited by: Mendell, Douglas, Bennett. 2005, Churchill Livingstone, Philadelphia, 2423-2434. 6Google Scholar
- Stoll BJ, Schuchat A: Maternal carriage of group B streptococci in developing countries. Pediatr Infect Dis J. 1998, 17: 499-503. 10.1097/00006454-199806000-00013.View ArticlePubMedGoogle Scholar
- Moyo SR, Mudzori J, Tswana , Maeland JA: Prevalence, capsular type distribution, anthropometric and obstetric factors of group B streptococcus (Streptococcus agalactiae) colonisation in pregnancy. Central Afr J Med. 2000, 46: 115-20.Google Scholar
- Lyamuya EF, Aboud S, Urassa WK, Sufi J, Mbwana J, Ndugulile F, Massambu C: Evaluation of simple rapid HIV assays and development of national rapid HIV test algorithms in Dar es Salaam, Tanzania. BMC Infect Dis. 2009, 18: 9-19.Google Scholar
- SPSS Inc version 13.0. the statistical Package for the Social Sciences. 2004, Chicago, II: SPSS IncGoogle Scholar
- United Republic of Tanzania, Ministry of Health: National AIDS Control Programme, Guidelines for HIV testing and counselling in clinical setting (PITC). 2008Google Scholar
- Suara RO, Adegbola RA, Baker CJ, Secka O, Mulholland EK, Greenwood BM: Carriage of Group B streptococci in pregnant Gambian mothers and their infants. Infect Dis. 1994, 170: 1316-19.View ArticleGoogle Scholar
- Orrett Fitzroy: Colonisation with Group B streptococci in pregnancy and outcome of infected neonates in Trinidad. Pediatric Intl. 2003, 45: 319-323. 10.1046/j.1442-200X.2003.01705.x.View ArticleGoogle Scholar
- Baker CJ, Edwards MS: Group B streptococcal infections. Infectious Diseases of the Fetus and Newborn Infant. Edited by: Remington JS, Klein JO. 2001, WB Saunders, Philadelphia, 1091-1156.Google Scholar
- Amin A, Abdulrazzaq YM, Uduman S: Group B Streptococcal Serotype Distribution of Isolates from Colonised Pregnant Women at the Time of Delivery in United Arab Emirates. J of Infect. 2002, 45: 42-46. 10.1053/jinf.2001.0990.View ArticleGoogle Scholar
- Schuchat A: Group B Streptococcus. Lancet. 1999, 353: 51-6. 10.1016/S0140-6736(98)07128-1.View ArticlePubMedGoogle Scholar
- Uh Y, Jang IH, Yoon KJ, Lee CH, Kwon JY, Kim MC: Colonisation rates and serotypes of group B streptococci isolated from pregnant women in a Korean tertiay hospital. Eur J Microbiol Infect Dis. 1997, 16: 753-6. 10.1007/BF01709259.View ArticleGoogle Scholar
- Regan JA, Klebanoff MA, Nugent RP: Vaginal Infection and Prematurity study Group, The epidemiology of group B streptococcal colonisation in pregnancy. Obstet Gynecol. 1991, 77: 604-610.PubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/9/437/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.